[1]
2026. Point-of-Care Manufacturing of Cell Therapies: A Perspective on Regulation at the Bedside. Translational Medicine & Therapeutics Journal. 5, 1 (Sep. 2026), 92–100. DOI:https://doi.org/10.5281/zenodo.22649515.